Journal of Thoracic Disease (@JTD_Journal) header
Journal of Thoracic Disease (@JTD_Journal) profile picture

Official X for Journal of Thoracic Disease. Peer-reviewed & OA. Respiratory, Lung, Heart, Esophagus & Mediastinum. Monthly. 📈 SCIE (IF 2.3), PubMed, Scopus.

Joined December 2025
Photo by Journal of Thoracic Disease (@JTD_Journal)Photo by Journal of Thoracic Disease (@JTD_Journal)Photo by Journal of Thoracic Disease (@JTD_Journal)Photo by Journal of Thoracic Disease (@JTD_Journal)Photo by Journal of Thoracic Disease (@JTD_Journal)Photo by Journal of Thoracic Disease (@JTD_Journal)Photo by Journal of Thoracic Disease (@JTD_Journal)Photo by Journal of Thoracic Disease (@JTD_Journal)Photo by Journal of Thoracic Disease (@JTD_Journal)Photo by Journal of Thoracic Disease (@JTD_Journal)
💡 New Issue Alert! The latest issue of Journal of Thoracic Disease (Vol 18, No 10) is now live! Featuring cutting-edge research and expert consensus spanning thoracic surgery, pulmonary medicine, and clinical innovations. 🫁✨ 🔍 Highlights include:• Adult primary snoring: modified Delphi consensus & AI-assisted evidence synthesis • Machine learning models for early identification of post-op pneumonia • Robotic-assisted vs. manual bronchoscopy advancements Dive into the full issue here: bit.ly/4BKyrRl #MedTwitter #ThoracicSurgery #Pulmonology #OpenAccess #JTD
16
Autumn October in Guangzhou, crisp air and full hearts. Today our Editor-in-Chief, Academician Nanshan Zhong, turns 90. The whole JTD team is celebrating with an original song, Ode to Nanshan: “You are the beacon shining bright, guiding us across darkest night…” Prof. Zhong founded JTD in 2009, building it into a world-class journal rooted in China and reaching worldwide. His messages to us: quality first, play fair, never cut corners. Thank you for lighting the way. Wishing you good health and many blessed years ahead. Happy 90th, Dr. Zhong!🎂 #JTD #ZhongNanshan #90thBirthday
1
1
21
📚 Latest Issue Alert! Journal of Thoracic Disease (JTD) Vol 16, No 9 is now live! 🫁✨ Discover the latest clinical research, reviews, and editorial comments in thoracic disease, surgery, and oncology. 📖 Read full open-access articles here: 🔗 bit.ly/4ztCijN #ThoracicSurgery #Pulmonology #Oncology #OpenAccess #MedTwitter
21
Connecting East & West in Respiratory Medicine! 🫁✨ The Journal of Thoracic Disease (JTD) enjoyed a wonderful time engaging with authors, reviewers, and global leaders at #ERSCongress2026 in Barcelona. Check out our exclusive interviews featuring Prof. Kian Fan Chung & Prof. Sir Peter J. Barnes, hosted by Prof. Ruchong Chen! 👇 🔗 bit.ly/46NU8Ss #RespiratoryMedicine #Asthma #COPD #Pulmonology #JTD
23
The Journal of Thoracic Disease (@JTD_journal) team is excited to be exhibiting at Booth V.12 in Fira Gran Via (Halls 1–3) from September 5–9! 🫁✨ Stop by our booth to: 📌 Catch up on our latest journal updates & special issues ✍️ Discuss prospective manuscript submissions directly with the editorial team 🤝 Network with fellow authors, reviewers, and board members We can’t wait to reconnect and thank you in person for your continued support. See you in Barcelona! 👋 #ERS2026 #ThoracicDisease #Pulmonology #AcademicPublishing #RespiratoryMedicine
1
1
74
Lung Hernia: An Updated Narrative Review Pulmonary herniation is no longer just a trauma story—it's an emerging challenge in post-thoracic surgery and lung transplantation patients. How should clinicians approach diagnosis & management today? Key Takeaways:🔍 Diagnosis: CT remains the gold standard—dynamic maneuvers (Cough/Valsalva) can help unmask dynamic defects. 🛠️ Management: Asymptomatic/small ➡️ conservative observation; severe pain, incarceration risk, or chest wall instability ➡️ surgical repair with selective reinforcement. ⚠️ The Gap: Standardized reporting & multicenter prospective data are urgently needed for high-risk cohorts. 📖 Read the full review by Dr. Vladislav Muldiiarov, Dr. Ashwini Arjuna, and the @NortonThoracic team: [bit.ly/4xhw6uA] #ThoracicSurgery #Pulmonology #LungTransplant #MedTwitter
34
📢 Out now! The latest issue of @JTD_journal is live. Explore cutting-edge research, clinical trials, and reviews in thoracic disease, lung cancer, and cardiovascular surgery. Stay updated with the latest evidence-based practice 🩺👇 🔗 bit.ly/4q7HoyU #ThoracicSurgery #Pulmonology #Oncology #MedicalResearch #OpenAccess
26
Are all solid NSCLC nodules aggressive? Not necessarily. 🧵 Growth kinetics in solid non-small cell lung cancer show significant heterogeneity. Here is a breakdown of our latest review on what this means for clinical decision-making: • The Standard Assumption: VDT < 400 days (rapid growth). • The Reality: Broad variability, with some indolent patterns stretching past 600 days. • The Tool: Deep learning & radiomics show huge promise in predicting individualized VDT, but need large-scale external validation. • The Future: Integrating AI models with multi-omics to understand the microenvironment drivers behind growth speed. Catch the full paper by Jiaqi Chen & Jianwei Wang: [bit.ly/4fcLiCO] #LungCancer #Oncology #Radiology #MedTwitter #NSCLC
39
💡 New in Heart Failure! How has the HF landscape shifted over the past year? Our latest review synthesizes landmark 2025 data, from breakthrough trials to cutting-edge device therapies. 📊 Key Highlights: 🔹 Trials: Insight from DAPA ACT HF-TIMI 68 & VICTOR trials. 🔹 Meds: Strong evidence for finerenone & tirzepatide in clinical practice. 🔹 Devices: Progress in preCARDIA & CRT-D, plus promising stem cell prospects. Despite GDMT success, rehospitalization remains high. What’s next for HF management? 🔗 Read the full 2025 Clinical Update here: [bit.ly/3T0Qcdg] #HeartFailure #Cardiology #CardioTwitter #MedEd #ClinicalTrial
23
🆕 New Issue Alert! 📢 Journal of Thoracic Disease Vol. 18, No. 6 (June 2026) is now online! 🎉 This issue features cutting-edge research on: 🔬 Lung cancer immunotherapy & biomarkers 🫁 Aortic dissection & TEVAR outcomes 🧬 NSCLC brain metastasis & ferroptosis 🏥 Minimally invasive thoracic surgery techniques 📖 Explore the full issue: [bit.ly/4oWj56p] #JTD #ThoracicSurgery #LungCancer #Cardiothoracic #MedicalResearch #OpenAccess
1
29
The latest Clarivate Journal Citation Reports (JCR) has noted the Journal of Thoracic Disease (JTD) Impact Factor at 2.3. We extend our sincere gratitude to our editorial board, reviewers, and authors. Your rigorous scientific contributions and dedication to the peer-review process remain the foundation of our progress in thoracic medicine. We remain committed to advancing open-access clinical research in respiratory and thoracic diseases. 📖 Click to explore more: [bit.ly/3Sj39yK] #JTD #ThoracicDisease #AcademicPublishing #MedTwitter
1
29
New research from RWTH Aachen on PE management! 🫁 A propensity score-matched analysis of 162 patients (81 pairs) shows that Ultrasound-facilitated catheter-directed thrombolysis (USAT) within a PERT pathway significantly improves outcomes compared to conventional therapy: 📉 Mortality: 2.5% vs 17.3% (P=0.003) 🏥 Hospital stay: 13.0 vs 17.5 days (P=0.008) 🩸 Major bleeding: 1.2% vs 11.1% (P=0.02) A promising move toward better hemodynamic support in high-risk PE. Read the full paper: [bit.ly/4vmju4c] #PulmonaryEmbolism #PERT #CriticalCare #MedTwitter #Cardiology
1
33
The latest issue of JTD is live! 🩺 Explore the newest insights in thoracic medicine, covering key developments in lung cancer, COPD, and more. Check out the full issue here: bit.ly/4ucrGmw #JTD #ThoracicMedicine #Pulmonology #RespiratoryHealth #OpenAccess
1
32
Best for a quick, high-impact update or for scheduling automated promotional slots. New Nationwide Data 🇯🇵 | A multi-center study of 3,546 patients by the Japanese Uniportal VATS Interest Group confirms the real-world safety and efficacy of uniportal thoracoscopic anatomical lung resections (2,780 lobectomies, 766 segmentectomies). Low 30-day mortality (0.3%) and conversion rates. Read the full paper: [bit.ly/4dwbRR3] #ThoracicSurgery #VATS #TSSMN
1
37
2D imaging has its limits, especially in complex lung resections. Why rely on mental 3D mapping when you can build a precise digital map for free? 🫁📍 Our new paper introduces a practical, open-source workflow for pulmonary bronchovascular reconstruction using @3DSlicerApp. Read more: [bit.ly/4eG9cXt]
43
The April 2026 issue of the Journal of Thoracic Disease is now live! 🫁 Vol 18, No 4 features the latest peer-reviewed research, clinical reviews, and editorial commentaries in thoracic surgery, oncology, and pulmonary medicine. Stay updated with the newest evidence-based insights: 🔗 bit.ly/4uz0cYL #JTD #ThoracicSurgery #PulmTwitter #Oncology #MedicalResearch @AMEPublishing
1
52
RATS vs. VATS: Can the robot match the gold standard during its "rookie" phase? 🤖🏥 A new study from @uOttawa and @OttawaHospital analyzes the initial implementation of a robotic thoracic program.@DrNikitaArora 📉 Mediastinal resections: RATS significantly shortened Length of Stay (1 day vs. 2 days). ✅ Lung resections: RATS showed comparable safety & LOS to established VATS. Full study here: [bit.ly/3Pjlgn7] #ThoracicSurgery #RATS #VATS #MedEd #SurgTwitter
3
77
What happened in pulmonary fibrosis research in 2025? 🫁 Our latest narrative review is out! We dive deep into the year’s major breakthroughs in basic & translational research: ✅ Advanced lung-on-a-chip & biomaterial models ✅ Deeper mechanistic insights (AEC repair, immune niches) ✅ The milestone approval of Nerandomilast & AI-derived drugs From signaling pathways to integrative perspectives—see where the field is heading next. 📈 [bit.ly/4cM4ncg] #PulmonaryFibrosis #IPF #TranslationalMedicine #LungResearch #OpenAccess
1
51
🩺 New RWD on adjuvant #Atezolizumab for completely resected stage II-III #NSCLC! ✨ Study Highlights: 📌 2-year DFS rate of 63.8%, with comparable efficacy across PD-L1 1-49% and ≥50% subgroups. 📌 Highly tolerable: No Grade 4-5 toxicities; 60% of patients completed the 1-year treatment cycle. Solid real-world evidence supporting its clinical utility and safety in everyday practice. Read the full study below👇 🔗 [bit.ly/4mVuwKn] #LungCancer #Oncology #LCSM #MedTwitter #Immunotherapy
46
New review: The role of thoracic ultrasound in fluid management in critical care Thoracic ultrasound (TUS) enables real-time assessment of lung congestion & fluid tolerance, supporting individualized decisions in ARDS, heart failure & shock. Introducing the FLUID framework for bedside reasoning. 🔗bit.ly/4tZRQcb #CriticalCare #Ultrasound #ARDS #ICU
38